Sterility of Glaucoma Medications among Chronic Users in the Community

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 2, 2004, Pages 123-128

  Porges, Yair ^a,b   Rothkoff, Levi ^a   Glick, Joseph ^a   Cohen, Shimon ^a  

^a LANIADO HOSPITAL   (Israel)

^b NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; NYOLOL; PILOCARPINE; TILOPTIC; TIMOLOL MALEATE; UNCLASSIFIED DRUG; VIOPTIC;

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CHRONIC PATIENT; CLINICAL ARTICLE; CONJUNCTIVITIS; CULTURE MEDIUM; DRUG CONTAMINATION; DRUG SAFETY; DRUG STERILITY; DRUG USE; FEMALE; GLAUCOMA; HUMAN; ISRAEL; KLEBSIELLA; LONG TERM CARE; MALE; MICROBIOLOGY; PATIENT COMPLIANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS;

AGED; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; DRUG CONTAMINATION; FEMALE; GLAUCOMA; HUMANS; KLEBSIELLA; MALE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS;

EID: 1842527049     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076804773710795     Document Type: Article

References (13)

1. Herreras, J.M., Pastor, J.C., Calonge, M., and Asensio, V.M. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology 99:1082-1088, 1992.
2. Baudouin, C. Side effects of antiglaucomatous drugs on the ocular surface. Curr. Opin. Ophthalmol. 7:80-86, 1996.
3. Baudouin, C., Pisella, P.J., Fillacier, K., Goldschild, M., Becquet, F., De Saint Jean, M., and Bechetoille, A. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106:556-563, 1999.
4. Schein, O.D., Wasson, P.J., Boruchoff, S.A., and Kenyon, K.R. Microbial keratitis associated with contaminated ocular medications. Am. J. Ophthalmol. 105:361-365, 1988.
5. Tempelton, W.C., Eiferman, R.A., Snyder, J.W., Melo, J.C., and Raff M.J. Serratia keratitis transmitted by contaminated eyedroppers. Am. J. Ophthalmol. 93:723-726, 1982.
6. Lwanga S.K., and Lemeshow S. Sample size determination in health studies. A Practical Manual. World Health Organization, Geneva, 1991, pp. 1-50.
7. Geyer, O., Bottone, E.J., Podos, S.M., Schumer, R.A., and Asbell, P.A. Microbial contamination of medications used to treat glaucoma. Br. J. Ophthalmol. 79:376-379, 1995.
8. Schein, O.D., Hibberd, P.L., Starck, T., Baker, A.S., and Kenyon, K.R. Microbial contamination of in-use ocular medications. Arch. Ophthalmol. 110:82-85, 1992.
9. Hovding, G., and Sjursen, H. Bacterial contamination of drops and dropper tips of in -use multidose eye-drop bottles. Acta Ophthalmol. 60:213-222, 1982.
10. Stevens, J.D., and Matheson, M.M. Survey of the contamination of eye drops of hospital inpatients and recommendations for the changing of current practice in eye drop dispensing. Br. J. Ophthalmol. 76:36-38, 1992.
11. Coad, C.T., Osato, M.S., and Wilhelmus, K.R. Bacterial contamination of eye drop dispensers. Am. J. Ophthalmol. 98:548-551, 1984.
12. Livingstone, D.J., Hanlon, G.W., and Dyke, S. Evaluation of the extended period of use for preserved eye drops in hospital practice. Br. J. Ophthalmol. 82:473-475, 1998.
13. Kim, G.E., Fern, K.D., and Perrigin, J.A. Sterility of ophthalmic drugs dispensed from spray bottles. Optom. Vis. Sci. 74:865-867, 1997.